Literature DB >> 32907857

Use of "normal" risk to improve understanding of dangers of covid-19.

David Spiegelhalter1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32907857     DOI： 10.1136/bmj.m3259

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  27 in total

1.  Age and frailty are independently associated with increased COVID-19 mortality and increased care needs in survivors: results of an international multi-centre study.

Authors:  Carly Welch
Journal:  Age Ageing       Date:  2021-05-05       Impact factor: 10.668

2.  Markers of systemic inflammation are positively associated with influenza vaccine antibody responses with a possible role for ILT2(+)CD57(+) NK-cells.

Authors:  Emilie Picard; Sarah Armstrong; Melissa K Andrew; Laura Haynes; Mark Loeb; Graham Pawelec; George A Kuchel; Janet E McElhaney; Chris P Verschoor
Journal:  Immun Ageing       Date:  2022-05-26       Impact factor: 9.701

3.  Factors associated with deaths due to COVID-19 versus other causes: population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform.

Authors:  Krishnan Bhaskaran; Sebastian Bacon; Stephen Jw Evans; Chris J Bates; Christopher T Rentsch; Brian MacKenna; Laurie Tomlinson; Alex J Walker; Anna Schultze; Caroline E Morton; Daniel Grint; Amir Mehrkar; Rosalind M Eggo; Peter Inglesby; Ian J Douglas; Helen I McDonald; Jonathan Cockburn; Elizabeth J Williamson; David Evans; Helen J Curtis; William J Hulme; John Parry; Frank Hester; Sam Harper; David Spiegelhalter; Liam Smeeth; Ben Goldacre
Journal:  Lancet Reg Health Eur       Date:  2021-05-08

4.  Sex differences in COVID-19 mortality in the Netherlands.

Authors:  Annabel Niessen; Anne C Teirlinck; Scott A McDonald; Wim van der Hoek; Rianne van Gageldonk-Lafeber; Mirjam J Knol
Journal:  Infection       Date:  2022-02-09       Impact factor: 7.455

5.  Second versus first wave of COVID-19 deaths: shifts in age distribution and in nursing home fatalities.

Authors:  John P A Ioannidis; Cathrine Axfors; Despina G Contopoulos-Ioannidis
Journal:  Environ Res       Date:  2021-02-10       Impact factor: 6.498

6.  Population perspective comparing COVID-19 to all and common causes of death during the first wave of the pandemic in seven European countries.

Authors:  Bayanne Olabi; Jayshree Bagaria; Sunil S Bhopal; Gwenetta D Curry; Nazmy Villarroel; Raj Bhopal
Journal:  Public Health Pract (Oxf)       Date:  2021-01-15

7.  The disproportionate excess mortality risk of COVID-19 in younger people with diabetes warrants vaccination prioritisation.

Authors:  Andrew P McGovern; Nick J Thomas; Sebastian J Vollmer; Andrew T Hattersley; Bilal A Mateen; John M Dennis
Journal:  Diabetologia       Date:  2021-02-16       Impact factor: 10.122

8.  Automatic Evaluation of the Lung Condition of COVID-19 Patients Using X-ray Images and Convolutional Neural Networks.

Authors:  Ivan Lorencin; Sandi Baressi Šegota; Nikola Anđelić; Anđela Blagojević; Tijana Šušteršić; Alen Protić; Miloš Arsenijević; Tomislav Ćabov; Nenad Filipović; Zlatan Car
Journal:  J Pers Med       Date:  2021-01-04

Review 9.  COVID-19: Rethinking the Lockdown Groupthink.

Authors:  Ari R Joffe
Journal:  Front Public Health       Date:  2021-02-26

10.  COVID-19 lockdown consequences on body mass index and perceived fragility related to physical activity: A worldwide cohort study.

Authors:  Constanta Urzeala; Martine Duclos; Ukadike Chris Ugbolue; Aura Bota; Mickael Berthon; Keri Kulik; David Thivel; Reza Bagheri; Yaodong Gu; Julien S Baker; Nicolas Andant; Bruno Pereira; Karine Rouffiac; Maëlys Clinchamps; Frédéric Dutheil
Journal:  Health Expect       Date:  2021-06-09       Impact factor: 3.318
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.